Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo
- PMID: 18490708
- PMCID: PMC2601684
- DOI: 10.4049/jimmunol.180.11.7107
Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo
Abstract
Transcription factor NF-kappaB controls the expression of multiple genes involved in immunity and inflammation. The initial activation and duration of NF-kappaB signaling is regulated by posttranslational modifications to IkappaB kinase, which earmarks inhibitors of NF-kappaB for degradation. Prior studies suggest that K63-linked ubiquitination of NEMO (NF-kappaB essential modulator), an IkappaB kinase regulatory subunit, is critical for NF-kappaB and MAPK signaling following engagement of Ag receptors. We now demonstrate that NF-kappaB and MAPK pathways are largely unaffected in primary cells from mice harboring a ubiquitination-defective form of NEMO, NEMO-KR. TLR- but not Ag receptor-induced cellular responses are impaired in NEMO-KR mice, which are more resistant to LPS-induced endotoxic shock than wild-type animals. Thus, one function of NEMO ubiquitination is to fine tune innate immune responses under TLR control.
Figures





Similar articles
-
Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1612-7. doi: 10.1073/pnas.1518163113. Epub 2016 Jan 22. Proc Natl Acad Sci U S A. 2016. PMID: 26802121 Free PMC article.
-
Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.J Virol. 2019 Jan 4;93(2):e00667-18. doi: 10.1128/JVI.00667-18. Print 2019 Jan 15. J Virol. 2019. PMID: 30404796 Free PMC article.
-
Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.Mol Cell Biol. 2008 May;28(10):3538-47. doi: 10.1128/MCB.02098-07. Epub 2008 Mar 17. Mol Cell Biol. 2008. PMID: 18347055 Free PMC article.
-
NEMO Family of Proteins as Polyubiquitin Receptors: Illustrating Non-Degradative Polyubiquitination's Roles in Health and Disease.Cells. 2025 Feb 18;14(4):304. doi: 10.3390/cells14040304. Cells. 2025. PMID: 39996775 Free PMC article. Review.
-
Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.Trends Cell Biol. 2006 Nov;16(11):569-77. doi: 10.1016/j.tcb.2006.09.004. Epub 2006 Sep 20. Trends Cell Biol. 2006. PMID: 16987664 Review.
Cited by
-
Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense.Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15856-61. doi: 10.1073/pnas.1004621107. Epub 2010 Aug 19. Proc Natl Acad Sci U S A. 2010. PMID: 20724660 Free PMC article.
-
Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO.Elife. 2020 Mar 23;9:e56095. doi: 10.7554/eLife.56095. Elife. 2020. PMID: 32202502 Free PMC article.
-
Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.J Cell Biochem. 2009 Dec 15;108(6):1337-45. doi: 10.1002/jcb.22364. J Cell Biochem. 2009. PMID: 19830703 Free PMC article.
-
NF-κB signaling and bone resorption.Osteoporos Int. 2013 Sep;24(9):2377-86. doi: 10.1007/s00198-013-2313-x. Epub 2013 Mar 7. Osteoporos Int. 2013. PMID: 23468073 Free PMC article. Review.
-
Linear ubiquitination in immunity.Immunol Rev. 2015 Jul;266(1):190-207. doi: 10.1111/imr.12309. Immunol Rev. 2015. PMID: 26085216 Free PMC article. Review.
References
-
- Li Q, Verma IM. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002;2:725–734. - PubMed
-
- Schulze-Luehrmann J, Ghosh S. Antigen-receptor signaling to nuclear factor κB. Immunity. 2006;25:701–715. - PubMed
-
- Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 2007;8:49–62. - PubMed
-
- Courtois G, Gilmore TD. Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene. 2006;25:6831–6843. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI061721/AI/NIAID NIH HHS/United States
- AI061721/AI/NIAID NIH HHS/United States
- HL068744/HL/NHLBI NIH HHS/United States
- R56 CA081065/CA/NCI NIH HHS/United States
- P01 HL068744/HL/NHLBI NIH HHS/United States
- R01 AI070305/AI/NIAID NIH HHS/United States
- CA081065/CA/NCI NIH HHS/United States
- AI070305/AI/NIAID NIH HHS/United States
- R01 HL054977/HL/NHLBI NIH HHS/United States
- CA082556/CA/NCI NIH HHS/United States
- R21 AI042284/AI/NIAID NIH HHS/United States
- R01 AI042284/AI/NIAID NIH HHS/United States
- R01 CA077474/CA/NCI NIH HHS/United States
- R01 AI052379/AI/NIAID NIH HHS/United States
- AI052379/AI/NIAID NIH HHS/United States
- R01 CA082556/CA/NCI NIH HHS/United States
- R01 HL121139/HL/NHLBI NIH HHS/United States
- AI042284/AI/NIAID NIH HHS/United States
- R01 CA081065/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous